- Q3 revenue $24.4B vs est $22.58B
- Mounjaro sales $10.72B, +65% YoY
- Zepbound sales $5.35B, +49% YoY
Sales of Mounjaro and Zepbound surged, pushing quarterly revenue to $24.4 billion, above estimates. The company raised its full-year revenue forecast for the third time this year. Shares rose 6.2%.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.